WORLDWIDE STRATEGIES INC - Quarter Report: 2008 October (Form 10-Q)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
ý
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For the
quarterly period ended October
31, 2008
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For the
transition period from ________________ to _______________
Commission
file number: 000-52362
Worldwide
Strategies Incorporated
(Exact
name of small business issuer as specified in its charter)
Nevada
|
41-0946897
|
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
3801
East Florida Avenue, Suite 400, Denver, Colorado
|
80210
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(303)
991-5887
(Registrant’s
telephone number, including area code)
Not
applicable
(Former
name, former address and former fiscal year, if changed since last
report)
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes ý No
o
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated filer,”
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act.
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting company ý
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes ý No
o
Indicate
the number of shares outstanding of each of the issuer’s classes of common
stock, as of the latest practicable date: As of December 16, 2008 – 9,301,234
shares of common stock
WORLDWIDE
STRATEGIES INCORPORATED
FORM
10-Q
FOR
THE FISCAL QUARTER ENDED
OCTOBER
31, 2008
INDEX
Page
|
||
PART
I. FINANCIAL INFORMATION
|
||
Item
1.
|
Financial
Statements
|
|
Consolidated
Condensed Balance Sheets
|
2
|
|
Consolidated
Condensed Statements of Operations
|
3
|
|
Consolidated
Condensed Statement of Changes in Shareholders’ Deficit
|
4
|
|
Consolidated
Condensed Statements of Cash Flows
|
5
|
|
Notes
to Consolidated Condensed Financial Statements (unaudited)
|
6
|
|
Item
2.
|
Management’s
Discussion and Analysis or Plan of Operation
|
13
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
18
|
Item
4.
|
Controls
and Procedures
|
18
|
PART
II. OTHER INFORMATION
|
||
Item
1.
|
Legal
Proceedings
|
18
|
Item
1A.
|
Risk
Factors
|
18
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
18
|
Item
3.
|
Defaults
Upon Senior Securities
|
19
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
19
|
Item
5.
|
Other
Information
|
19
|
Item
6.
|
Exhibits
|
19
|
SIGNATURES
|
21
|
1
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Consolidated
Condensed Balance Sheet
October
31,
|
July
31,
|
|||||||
2008
|
2008
|
|||||||
(unaudited)
|
(audited)
|
|||||||
Assets
|
||||||||
Current
Assets:
|
||||||||
Cash
|
$ | 652 | $ | 7,308 | ||||
Prepaid
expenses
|
15,588 | 24,477 | ||||||
Total
current assets
|
16,240 | 31,785 | ||||||
Office
equipment, net of accumulated depreciation of $21,489 (Note
1)
|
1,134 | 2,530 | ||||||
Deposits
|
150 | 150 | ||||||
Total
assets
|
$ | 17,524 | $ | 34,465 | ||||
Liabilities
and Shareholders’ Deficit
|
||||||||
Current
Liabilities:
|
||||||||
Accounts
and notes payable:
|
||||||||
Accounts
payable
|
$ | 59,934 | $ | 47,853 | ||||
Accounts
payable, related party (Note 2)
|
5,391 | 4,000 | ||||||
Accrued
salaries (Note 3)
|
642,537 | 551,687 | ||||||
Accrued
liabilities (Note 6)
|
11,743 | 8,852 | ||||||
Accrued
liabilities, related party (Note 4)
|
2,197 | 2,149 | ||||||
Notes
payable (Note 6)
|
317,551 | 315,790 | ||||||
Notes
payable, related party (Note 4)
|
320,784 | 313,725 | ||||||
Total
current liabilities
|
1,360,137 | 1,244,056 | ||||||
Shareholders’
deficit (Notes 5 and 9):
|
||||||||
Common
stock
|
9,302 | 9,284 | ||||||
Additional
paid-in capital
|
4,858,487 | 4,835,975 | ||||||
Deficit
accumulated during development stage
|
(6,210,402 | ) | (6,054,850 | ) | ||||
Total
shareholders’ deficit
|
(1,342,613 | ) | (1,209,591 | ) | ||||
Total
liabilities and shareholders’ deficit
|
$ | 17,524 | $ | 34,465 |
See
accompanying notes to consolidated condensed financial statements
2
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Consolidated
Condensed Statement of Operations
(Unaudited)
March
1, 2005
|
||||||||||||
(Inception)
|
||||||||||||
Three
Months Ended
|
Through
|
|||||||||||
October
31,
|
October
31,
|
|||||||||||
2008
|
2007
|
2008
|
||||||||||
Sales
|
$ | — | $ | — | $ | 34,518 | ||||||
Cost
of sales
|
— | — | 30,568 | |||||||||
— | — | 3,950 | ||||||||||
Operating
expenses:
|
||||||||||||
Salaries,
benefits and payroll taxes
|
61,335 | 65,714 | 866,500 | |||||||||
Stock
based compensation (Note 5)
|
— | 350 | 3,190,203 | |||||||||
Professional
and consulting fees
|
23,429 | 38,607 | 737,408 | |||||||||
Travel
|
1,991 | 5,105 | 220,834 | |||||||||
Contract
labor
|
37,500 | 37,500 | 389,250 | |||||||||
Insurance
|
12,475 | 12,546 | 201,953 | |||||||||
Depreciation
|
1,395 | 14,282 | 139,144 | |||||||||
Loss
on failed acquisition
|
— | — | 181,016 | |||||||||
Other
general and administrative expenses
|
3,199 | 4,849 | 188,147 | |||||||||
Total
operating expenses
|
141,324 | 178,953 | 6,114,455 | |||||||||
Loss
from operations
|
(141,324 | ) | (178,953 | ) | (6,110,505 | ) | ||||||
Other
expense:
|
||||||||||||
Interest
expense
|
(14,228 | ) | (10,609 | ) | (99,897 | ) | ||||||
Loss
before income taxes
|
(155,552 | ) | (189,562 | ) | (6,210,402 | ) | ||||||
Income
tax provision (Note 7)
|
— | — | — | |||||||||
Net
loss
|
$ | (155,552 | ) | $ | (189,562 | ) | $ | (6,210,402 | ) | |||
Basic
and diluted loss per share
|
$ | (0.02 | ) | $ | (0.02 | ) | ||||||
Basic
and diluted weighted average
|
||||||||||||
common
shares outstanding
|
9,301,234 | 8,691,791 |
See
accompanying notes to consolidated condensed financial statements
3
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Consolidated
Condensed Statement of Changes in Shareholders’ Deficit
(Unaudited)
Deficit
|
||||||||||||||||||||
Accumulated
|
||||||||||||||||||||
Additional
|
During
|
|||||||||||||||||||
Common
Stock
|
Paid-In
|
Development
|
||||||||||||||||||
Shares
|
Par
Value
|
Capital
|
Stage
|
Total
|
||||||||||||||||
Balance
at July 31, 2008
|
9,283,211 | $ | 9,284 | $ | 4,835,975 | $ | (6,054,850 | ) | $ | (1,209,591 | ) | |||||||||
Common
stock issued in exchange for
|
||||||||||||||||||||
interest
(Note 5)
|
18,023 | 18 | 2,452 | — | 2,470 | |||||||||||||||
Deposit
on proposed acquisition (Note 8)
|
— | — | 20,000 | — | 20,000 | |||||||||||||||
Expenses
paid-capital contribution (Note 5)
|
— | — | 60 | — | 60 | |||||||||||||||
Net
loss
|
— | — | — | (155,552 | ) | (155,552 | ) | |||||||||||||
Balance
at October 31, 2008
|
9,301,234 | $ | 9,302 | $ | 4,858,487 | $ | (6,210,402 | ) | $ | (1,342,613 | ) |
See
accompanying notes to consolidated condensed financial statements
4
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Consolidated
Condensed Statement of Cash Flows
(Unaudited)
March
1, 2005
|
||||||||||||
(Inception)
|
||||||||||||
Three
Months Ended
|
Through
|
|||||||||||
October
31,
|
October
31,
|
|||||||||||
2008
|
2007
|
2008
|
||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
cash used in
|
||||||||||||
Operating
activities
|
$ | (26,656 | ) | $ | (60,474 | ) | $ | (1,967,410 | ) | |||
Cash
flows from investing activities:
|
||||||||||||
Cash
acquired in Centric acquisition
|
— | — | 6 | |||||||||
Purchases
of equipment
|
— | — | (23,612 | ) | ||||||||
Deposit
paid on Cascade acquisition
|
— | — | (100,000 | ) | ||||||||
Net
cash used in
|
||||||||||||
Investing
activities
|
— | — | (123,606 | ) | ||||||||
Cash
flows from financing activities:
|
||||||||||||
Proceeds
from sale of common stock
|
— | — | 1,587,706 | |||||||||
Deposit
on proposed acquisition (Note 8)
|
20,000 | — | 70,000 | |||||||||
Payments
for offering costs
|
— | — | (150,339 | ) | ||||||||
Proceeds
from notes payable, related party
|
— | 24,500 | 276,301 | |||||||||
Proceeds
from notes payable
|
— | 17,000 | 308,000 | |||||||||
Net
cash provided by
|
||||||||||||
Financing
activities
|
20,000 | 41,500 | 2,091,668 | |||||||||
Net
change in cash
|
(6,656 | ) | (18,974 | ) | 652 | |||||||
Cash,
beginning of period
|
7,308 | 33,443 | — | |||||||||
Cash,
end of period
|
$ | 652 | $ | 14,469 | $ | 652 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Cash
paid during the period for:
|
||||||||||||
Income
taxes
|
$ | — | $ | — | $ | — | ||||||
Interest
|
$ | — | $ | — | $ | 7,518 | ||||||
Non-cash
investing/financing activities
|
||||||||||||
Common
stock issued to repay loan
|
$ | $ | 75,000 | $ | 75,000 | |||||||
Common
stock issued to acquire Centric
|
$ | — | $ | — | $ | 41,673 | ||||||
Offering
costs exchanged for stock
|
$ | — | $ | — | $ | 6,500 |
See
accompanying notes to consolidated condensed financial statements
5
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
(1) Organization
, Basis of Presentation, and Summary of Significant Accounting
Policies
Organization
and Basis of Presentation
Worldwide
Strategies Incorporated (the “Company”) was incorporated on March 1, 2005 as
Worldwide Business Solutions Incorporated (“WBSI”) in the State of
Colorado. The Company intends to provide call center software
platforms to client centers and to outsource selected client services to
multi-lingual international centers.
On May
13, 2005, Barnett Energy Corporation (“BEC”), a Nevada corporation, entered into
a Share Exchange Agreement (the “Agreement”) with WBSI. Under the terms of the
Agreement, BEC agreed to acquire all of the issued and outstanding common stock
of WBSI in exchange for 778,539 shares of its common stock. The
acquisition closed on July 8, 2005. Following the acquisition, the
former shareholders of WBSI held approximately 76.8 percent of BEC’s outstanding
common stock, resulting in a change of control. In addition, WBSI
became a wholly owned subsidiary of BEC. However, for accounting
purposes, the acquisition has been treated as a recapitalization of WBSI, with
BEC the legal surviving entity. Since BEC had minimal assets and no
operations, the recapitalization has been accounted for as the sale of 778,539
shares of WBSI common stock for the net liabilities of
BEC. Therefore, the historical financial information prior to the
date of the recapitalization is the financial information of WBSI.
On June
14, 2005, BEC changed its name to Worldwide Strategies
Incorporated.
Effective
July 31, 2007 the Company filed a Certificate of Change Pursuant to NRS 78.209,
which decreased the number of its authorized shares of common stock from
100,000,000 to 33,333,333 and reduced the number of common shares issued and
outstanding from 17,768,607 to 5,923,106.
All
shares and per share amounts in these Consolidated Financial Statements and
related notes have been retroactively adjusted to reflect the reverse stock
split for all periods presented.
On July
31, 2007, the Company acquired 100% of the issued and outstanding shares of
Centric Rx, Inc., (“Centric”) in exchange for 2,250,000 shares of the Company’s
common stock. As a result of the acquisition, Centric is now a wholly
owned subsidiary of the Company and the results of its operation will be
included in the Company’s consolidated financial
statements. Centric’s primary business will be the distribution of
health services and prescription drug discount cards. The Company
plans to contract with call centers to provide ongoing service and support to
organizations and individuals that utilize these cards. Centric will receive
commission based upon the utilization of these cards.
Development
Stage
The
Company and its subsidiaries are in the development stage in accordance with
Statements of Financial Accounting Standards (SFAS) No. 7 “Accounting and
Reporting by Development Stage Enterprises”. As of October 31, 2008,
the Company has devoted substantially all of its efforts to financial planning,
raising capital and developing markets.
Going
Concern
The
accompanying financial statements have been prepared in conformity with
generally accepted accounting principles in the United States, which contemplate
continuation of the Company as a going concern. However, the Company
experienced net losses of $155,552, $189,562, and $6,210,402 for the periods
ended October 31, 2008, October 31, 2007 and for the period from March 1, 2005
(inception) through October 31, 2008, respectively. In addition, the
Company has incurred liabilities in excess of assets over the past quarter and,
as of October 31, 2008, and has an accumulated deficit of
$6,210,402. These matters, among others, raise substantial doubt
about its ability to continue as a going concern.
6
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
In view
of the matters described above, recoverability of a major portion of the
recorded asset amounts shown in the accompanying balance sheet is dependent upon
the Company’s ability to generate sufficient sales volume to cover its operating
expenses and to raise sufficient capital to meet its payment
obligations. Historically, management has been able to raise
additional capital. During the period ended October 31, 2008, the Company
obtained an additional $20,000 as partial payment of item (ii) in the NMKT
letter of intent.
The
financial statements do not include any adjustments relating to the
recoverability and classification of recorded asset amounts, or amounts and
classification of liabilities that might be necessary should the Company be
unable to continue in existence.
Principles
of Consolidation
The
accompanying Consolidated Financial Statements include the Company’s accounts
and those of its wholly owned subsidiaries. All significant
intercompany transactions and balances have been eliminated in
consolidation.
Use
of Estimates
The
preparation of financial statements in accordance with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and the disclosure of
contingent assets and liabilities at the date of financial statements and the
reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those
estimates.
Cash
and Cash Equivalents
The
Company considers all highly liquid debt instruments with original maturities of
three months or less when acquired to be cash equivalents. The
Company had no cash equivalents at October 31, 2008.
Financial
Instruments
The
carrying amounts of cash and current liabilities approximate fair value due to
the short-term maturity of the instruments.
Property
and Equipment
Property
and equipment are stated at cost. Depreciation is calculated using
the straight-line method over the estimated useful lives of the related assets,
currently ranging from three to five years. Expenditures for
additions and improvements are capitalized, while repairs and maintenance costs
are expensed as incurred. The cost and related accumulated
depreciation of property and equipment sold or otherwise disposed of are removed
from the accounts and any gain or loss is recorded in the year of
disposal.
October
31,
|
||||||||
2008
|
2007
|
|||||||
Office
equipment
|
$ | 10,600 | $ | 11,589 | ||||
Software
|
12,023 | 128,690 | ||||||
22,623 | 140,279 | |||||||
Accumulated
depreciation
|
(21,489 | ) | (27,296 | ) | ||||
Property
and equipment - net
|
$ | 1,134 | $ | 112,983 |
The
Company determined that software acquired, as part of the assets of Centric
purchased July 31, 2007, has no future value. The Company will not
pursue the stand-alone pharmacy development, supported by the software, as
originally contemplated in the Centric. The useful life of this asset
originally expected to end October 31, 2009 was revised to end July 31, 2008.
This asset and a fully depreciated computer, no longer in service were
abandoned
7
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
during
the first quarter ended October 31, 2008 and removed from the Company’s records.
As the carrying amount of the assets was $0 no impairment loss was
recognized.
Depreciation
expense for the quarters ended October 31, 2008, October 31, 2007, and for the
period from March 1, 2005 (inception) through October 31, 2008 totaled $1,395,
$14,282, and $139,144, respectively.
Impairment
of Long-Lived Assets
The
Company evaluates the carrying value of its long-lived assets under the
provisions of SFAS No. 144, “Accounting for the Impairment or Disposal of
Long-Lived Assets”. Statement No. 144 requires impairment losses to
be recorded on long-lived assets used in operations when indicators of
impairment are present and the undiscounted future cash flows estimated to be
generated by those assets are less than the assets’ carrying amount. If such
assets are impaired, the impairment to be recognized is measured by the amount
by which the carrying amount of the assets exceeds the fair value of the
assets.
Offering
Costs
The
Company defers offering costs, such as legal, commissions and printing costs,
until such time as the offering is completed. At that time, the Company offsets
the offering costs against the proceeds from the offering. If an offering is
unsuccessful the costs are charged to operations at that time.
Income
Taxes
Income
taxes are provided for the tax effects of transactions reported in the financial
statements and consist of taxes currently due plus deferred taxes related
primarily to differences between the recorded book basis and the tax basis of
assets and liabilities for financial and income tax
reporting. Deferred tax assets and liabilities represent the future
tax return consequences of those differences, which will either be taxable or
deductible when the assets and liabilities are recovered or
settled. Deferred taxes are also recognized for operating losses that
are available to offset future taxable income and tax credits that are available
to offset future federal income taxes.
Revenue
Recognition
The
Company provides its call center services under contract
arrangements. The Company recognizes revenue as services are provided
(based on an hourly rate) over the term of the contract.
Stock-based
Compensation
Effective
February 1, 2006, the Company adopted SFAS No. 123R, “Share Based
Payment”. SFAS 123R requires a public entity to measure the cost of
employee services received in exchange for an award of equity instruments based
on the grant-date fair value of the award (with limited
exceptions). In prior years, employee stock-based compensation awards
were measured based on the intrinsic value method prescribed in Accounting
Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”), and
complied with the disclosure provisions of SFAS No. 123, “Accounting for
Stock-Based Compensation” (“SFAS 123”), and SFAS No. 148, “Accounting for
Stock-Based Compensation-Transition and Disclosure”. Under APB 25,
compensation expense of fixed stock options was based on the difference, if any,
on the date of the grant between the deemed fair value of the Company’s stock
and the exercise price of the option. Compensation expense was
recognized on the date of grant or on the straight-line basis over the
option-vesting period. The Company accounts for stock issued to
non-employees in accordance with the provisions of SFAS 123 and EITF Issue No.
96-18, “Accounting for Equity Instruments That Are Issued to Other Than
Employees for Acquiring, or in Conjunction with Selling, Goods or
Services”. As a result of the change in accounting policy, the
Company recorded $0, $350, and $3,190,203 as stock-based compensation on the
stock options granted during the quarters ended October 31, 2008, October 31,
2007 and for the period from March 1, 2005 (inception) through October 31,
2008.
8
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
Loss
per Common Share
The
Company reports net loss per share using a dual presentation of basic and
diluted loss per share. Basic net loss per share excludes the impact of common
stock equivalents. Diluted net loss per share utilizes the average
market price per share when applying the treasury stock method in determining
common stock equivalents. As of October 31, 2008, after recognition
of the one for three reverse stock split, there were 6,124,695 and 5,033,364
vested common stock options and warrants outstanding, respectively, which were
excluded from the calculation of net loss per share-diluted because they were
antidilutive.
Fiscal
Year-end
The
Company’s year-end is July 31.
New
Accounting Pronouncements
In May
2008, the Financial Accounting Standards Board (“FASB”) issued Statement of
Financial Accounting Standards (“SFAS”) No. 163, “Accounting for Financial Guarantee
Insurance Contracts – an interpretation of FASB Statement No.
60.” SFAS No. 163 prescribes accounting for insures of
financial obligations, bringing consistency to recognizing and recording
premiums and to loss recognition. SFAS No. 163 also requires expanded
disclosures about financial guarantee insurance contracts. Except for
some disclosures, SFAS No. 163 is effective for financial statements issued for
fiscal years beginning after December 15, 2008. The adoption of SFAS
No. 163 will not have an impact on our results of operations or financial
position.
In May
2008, the FASB issued SFAS No. 162, “The Hierarchy of Generally Accepted
Accounting Principles.” SFAS No. 162 makes the hierarchy of
generally accepted accounting principles explicitly and directly applicable to
preparers of financial statements, a step that recognizes preparers’
responsibilities for selecting the accounting principles for their financial
statements. The effective date of SFAS No. 162 is 60 days following
the U.S. Securities and Exchange Commission’s approval of the Public Company
Accounting Oversight Board’s related amendments to remove the GAAP hierarchy
from auditing standards, where it has resided for some time. The
adoption of SFAS No. 162 will not have an impact on our results of operations or
financial position.
On March
19, 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative
Instruments and Hedging Activities, an amendment of FASB Statement No.
133.” SFAS No. 161 requires enhanced disclosures about an
entity’s derivative and hedging activities. These enhanced
disclosures will discuss (a) how and why an entity uses derivative instruments,
(b) how derivative instruments and related hedged items are accounted for under
Statement No. 133 and its related interpretations, and (c) how derivative
instruments and related hedged items affect an entity’s financial position,
financial performance, and cash flows. SFAS No. 161 is effective for
financial statements issued for fiscal years and interim periods beginning after
November 15, 2008. We have not determined the impact, if any SFAS No.
161 will have on our consolidated financial statements.
(2) Accounts
payable related parties
At
October 31, 2008, the Company was indebted to two officers and a director for
expenses incurred on behalf of the Company totaling $5,391.
(3) Accrued
compensation
The
Company has not compensated the Chief Executive Officer or the Chief Financial
Officer for services rendered during the 2007 and 2008 fiscal years and the
first quarter of the 2009 fiscal year. The unpaid compensation has
been accrued and charged to expense for these periods. Accrued
compensation totals $642,537 at October 31, 2008. The accrued
salaries will only be paid if the Company successfully obtains sufficient
financing to fund its plan of operation.
9
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
(4) Related
party transactions
Convertible
notes payable
Outstanding
notes, including accrued interest which was capitalized, total $320,784 at
October 31, 2008. Accrued interest totals $2,197 at October 31,
2008. Interest expense for the three months ended October 31, 2008
and 2007, and for the period from March 1, 2005 (inception) to October 31, 2008
was $7,107, $5,518 and $50,152, respectively. The notes are also
convertible into shares of the Company’s common stock at the option of the note
holder after the maturity date. Any unpaid principal and interest may
be converted into the Company’s common stock at various rates, or 2,934,913
shares. At October 31, 2008, the Company is in default on all
outstanding notes and the option to convert is available.
Subsequent
to October 31, 2008 the Company made an offer to the note-holders allowing them
to convert their outstanding notes to convertible preferred shares (see Note 9)
the Company’s offer was accepted by all notes-holders.
(5) Shareholders’
Deficit
Common
stock
In
September 2008, the Company issued a total of 18,023 shares of the Company’s
common stock in exchange for $2,470 in interest on five convertible notes
payable. The shares were valued based on the fair value of the shares
in the month interest was accrued.
Capital
contribution
During
the quarter ended October 31, 2008, the president of Centric paid office
expenses totaling $60 on behalf of the Company.
Stock
Options and Warrants
Following
is a schedule of changes in common stock options and warrants from July 31, 2008
through October 31, 2008:
Weighted
|
Weighted
|
|||||||||
Average
|
Average
|
|||||||||
Exercise
|
Exercise
|
Remaining
|
||||||||
Awards
Outstanding
|
Price
|
Price
|
Contractual
|
|||||||
Total
|
Exercisable
|
Per
Share
|
Per
Share
|
Life
|
||||||
Outstanding
at July 31, 2008
|
11,158,059
|
11,158,059
|
$0.06-$3.36
|
$
|
0.45
|
3.16
years
|
||||
Granted
|
—
|
—
|
—
|
—
|
N/A
|
|||||
Exercised
|
—
|
—
|
—
|
—
|
N/A
|
|||||
Cancelled/Expired
|
—
|
—
|
—
|
—
|
N/A
|
|||||
Outstanding
at October 31, 2008
|
11,158,059
|
11,158,059
|
$0.06-$3.36
|
$
|
0.45
|
3.02
years
|
Common
stock awards consisted of the following options and warrants during the period
from July 31, 2007 through October 31, 2008:
Description
|
Options
|
Warrants
|
Total
Awards
|
|||||||||
Outstanding
at July 31, 2008
|
6,124,695 | 5,033,364 | 11,158,059 | |||||||||
Granted
|
— | — | — | |||||||||
Exercised
|
— | — | — | |||||||||
Cancelled/Expired
|
— | — | — | |||||||||
Outstanding
at October 31, 2008
|
6,124,695 | 5,033,364 | 11,158,059 |
10
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
Preferred
stock
The
Company is authorized to issue 25,000,000 shares of $.001 par value preferred
stock. The Company’s Board of Directors may divide and issue the
preferred shares in series. Each Series, when issued, shall be
designated to distinguish them from the shares of all other
series. The relative rights and preferences of these series include
preference of dividends, redemption terms and conditions, amount payable upon
shares of voluntary or involuntary liquidation, terms and condition of
conversion as well as voting powers.
(6) Notes
payable
Outstanding
notes, including accrued interest which was capitalized, total $317,551 at
October 31, 2008. Accrued interest totals $11,743 at October 31,
2008. Interest expense for the three months ended October 31, 2008
and 2007, and for the period from March 1, 2005 (inception) to October 31, 2008
was $7,121, $5,091 and $49,745, respectively. The notes are also
convertible into shares of the Company’s common stock at the option of the note
holder after the maturity dates. Any unpaid principal and interest
may be converted into the Company’s common stock at various rates, or 4,129,898
shares. At October 31, 2008, the Company is in default on all outstanding notes
and the option to convert is available.
Subsequent
to October 31, 2008, the Company made an offer to the note holders to exchange
their outstanding notes for convertible preferred stock. All of the
note holders have indicated that they will accept the exchange of their
outstanding notes for convertible preferred stock (see Note 9).
(7) Income
Taxes
The
Company records its income taxes in accordance with SFAS No. 109, “Accounting
for Income Taxes”. The Company incurred net operating losses during
all periods presented resulting in a deferred tax asset, which was fully allowed
for; therefore, the net benefits and expense resulted in $0 income
taxes.
(8) Letters
of Intent
NewMarket
Technology, Inc.
In
February 2008, the Company entered into a letter of intent with NewMarket
Technology, Inc. (“NMKT”). Pursuant to the letter of intent, NMKT will acquire a
51% in the Company in exchange for (i) the assumption of all of the Company’s
outstanding debts and (ii) the payment of $100,000. NMKT’s ownership
interest will be protected from dilution for three years. The
transaction is subject to the execution of a mutually satisfactory definitive
stock purchase agreement and the completion of due
diligence. Withdrawal from the transaction by either party will
subject the withdrawing party to a claim for the legal and due diligence
expenses of the other party, not to exceed $100,000.
In August
2008 and April 2008, the Company received $20,000 and $50,000, respectively,
from NMKT as partial payment of item (ii) in the letter of
intent. Both parties are engaged in negotiating a mutually
satisfactory definitive stock purchase agreement and the completion of due
diligence.
11
WORLDWIDE
STRATEGIES INCORPORATED
(A
Development Stage Company)
Notes
to Consolidated Condensed Financial Statements
(Unaudited)
(9) Subsequent
Events
Preferred
Stock and Debt Conversion
Effective
December 15, 2008, the Company has established a series of 5,000,000 shares of
preferred stock to be known as “Series A Convertible Preferred Stock” (“Series
A”). The shares of Series A have a par value of $.001 per
share. Shares of Series A may be redeemed, for $0.50 per share, at
the Company’s option. Each share of Series A may be converted into
6.25 shares of common stock, at the option of the holder.
Shares of
Series A will participate in dividends paid, in cash or other property, to
holders of outstanding common stock. In the event the Company
declares and pays a dividend to common stockholders, five percent (5%) of the
value of such dividend shall be paid to the holders of outstanding Series A
shares. After payment of the 5% preference, each outstanding Series A
share will participate in the distribution of the remaining 95% of the dividend
with the holders of common stock, as if each outstanding Series A share were one
share of common stock. Any dividend payable to holders of Series A
shares will have the same record and payment date and terms as the dividend
payable on the common stock.
Holders
Series A shares shall be entitled to vote together with the holders of the
common stock as a single class, upon all matters submitted to holders of common
stock for a vote. Shares of Series A will vote that number of votes
equal to the number of shares of common stock issuable upon conversion of one
share of Series A, as adjusted from time-to-time. Whenever holders of
Series A are required or permitted to take any action by separate class or
series, such action may be taken without a meeting by written consent, setting
forth the action so taken and signed by the holders of the outstanding Series A
shares having not less than the minimum number of votes that would be necessary
to authorize or take such action at a meeting at which all shares entitled to
vote thereon were present and voted.
On
December 8, 2008, the Company made an offer of shares Series A preferred stock
at $0.50 per share to its holders of convertible notes. The offer was
of exchange was made for the amount owing on indebtedness as of October 31,
2008. This offer was extended to include accrued salaries at October
31, 2008 and debt associated with working capital provided in November
2008.
The
Company’s offer has been accepted by all debt holders. As of the date
of this report, the exchange of debt for Series A has not been
finalized. When the exchange is finalized, the Company’s debt will be
converted into 2,605,624 Series A shares. These Series A shares may
be converted into 16,285,150 shares of the Company’s common
stock. These Series A shares will also have voting rights equal to
16,285,150 shares of the Company’s common stock. Upon completion of
the exchange of debt for Series A shares, the Company will experience a change
of control.
Cash
Advances
During
November 2008, the Company received cash from three individuals in the amount of
$8,000 to be used as working capital.
Letter
of intent
During
November 2008, the Company received $5,000 from NMKT as partial payment of the
$100,000 payment require by the letter of intent.
12
Item
2. Management’s
Discussion and Analysis or Plan of Operation
General
The
following discussion and analysis should be read in conjunction with our
financial statements and related footnotes for the periods ended July 31, 2008
included in our Annual Report on Form 10-K. The discussion of
results, causes and trends should not be construed to imply any conclusion that
such results or trends will necessarily continue in the future.
Overview
Worldwide
Strategies Incorporated (“we”, “us”, or “our”) was originally incorporated in
the State of Nevada on April 6, 1998 as Boyd Energy Corporation for the purpose
of developing a mechanical lifting device that would enhance existing stripper
well production. We were unable to raise sufficient capital to carry
out this business and focused instead on leasing properties and exploring for
oil and gas. We changed our name to Barnett Energy Corporation on
July 17, 2001.
On July
8, 2005, pursuant to a Share Exchange Agreement with Worldwide Business
Solutions Incorporated, a Colorado corporation (“WBSI”), we acquired all of the
issued and outstanding capital stock of WBSI, in exchange for 2,573,335 shares
of our common stock. As a result of this share exchange, shareholders
of WBSI as a group owned approximately 76.8% of the shares then outstanding, and
WBSI became our wholly-owned subsidiary. We changed our name to
Worldwide Strategies Incorporated as of June 14, 2005.
For
accounting purposes, the acquisition of WBSI was accounted for as a
recapitalization of WBSI. Since we had only minimal assets and no
operations, the recapitalization has been accounted for as the sale of 778,539
shares of WBSI common stock for our net liabilities at the time of the
transaction. Therefore, the historical financial information prior to
the date of the recapitalization is the financial information of
WBSI.
WBSI was
incorporated on March 1, 2005 to provide Business Process Outsourcing (“BPO”)
services. WBSI intends to focus initially on providing call center
services, but may expand to providing other outsourced services if it implements
successfully its business plan.
WBSI
incorporated a subsidiary, Worldwide Business Solutions Limited, in the United
Kingdom under the Companies Acts 1985 and 1989, on May 31, 2005. This
U.K. subsidiary was formed for the purpose of supporting sales and marketing
efforts in English-speaking countries. While the subsidiary has a
temporary office and bank accounts established, it does not yet have any
employees.
On July
31, 2007, we acquired 100% of the issued and outstanding shares of Centric Rx,
Inc., a Nevada corporation (“Centric”) in exchange for 2,250,000
post-reverse-split shares of our common stock. We filed Articles of
Exchange Pursuant to NRS 92A.200 effective July 31, 2007. Centric is
now our wholly-owned subsidiary and will operate as a health services and
pharmacy solution provider.
Effective
July 31, 2007, we filed a Certificate of Change Pursuant to NRS 78.209, which
decreased the number of our authorized shares of common stock from 100,000,000
to 33,333,333 and reduced the number of common shares issued and outstanding
immediately prior to filing from 17,768,607 to 5,923,106.
Plan
of Operation
On
February 14, 2008, we entered into a letter of intent with NewMarket Technology,
Inc. (“NMKT”). It is proposed that NMKT will acquire a 51% interest
in our Company in exchange for (i) the assumption of all of our outstanding
debts and (ii) the payment of $100,000. NMKT’s ownership interest
would be protected from dilution for three years. If we are able to
complete the transaction with NMKT, a change of control will occur and a new
plan of operation will be pursued by the new officers and directors of our
Company. To date, we have received $75,000 from NMKT as part of the
$100,000 non-refundable deposit NMKT agreed to pay in the letter of
intent. We are not obligated to return any portion of the $75,000 we
have received, even if we do not complete the transaction with
NMKT.
13
If we do
not complete the transaction with NMKT, we will continue to pursue debt and/or
equity financing to continue operations. Failure to obtain additional
financing could result in the cessation of our business. We cannot
assure you that we will be able to complete any additional financings
successfully.
We may
attempt to market the Company as a “shell company” as we believe that its status
as a reporting company whose stock is quoted on the OTC Bulletin Board has
value. We cannot assure you that we will be successful in this
effort.
Effective
December 15, 2008, we have designated 5,000,000 shares of our authorized
preferred stock as “Series A Convertible Preferred Stock” (“Series
A”). We have offered all of our convertible note holders and various
other debt holders an exchange of Series A shares for the outstanding debts and
any accrued interest at $0.50 per Series A share. All of our debt
holders have indicated that they will exchange their debt for the Series A
shares. Among other things, each Series A share can be converted into
6.25 common shares and has the right to a vote equal to 6.25 common shares on
all matters to be voted upon by common stockholders. We anticipate
that we will issue 2,605,624 Series A shares in exchange for the release of
approximately $1,302,812 of outstanding debt and accrued
liabilities. The completion of this exchange will effect a change of
control of our Company.
Significant
Accounting Policies and Estimates
Our
discussion and analysis of our financial condition and results of operations are
based upon our consolidated condensed financial statements, which have been
prepared in accordance with accounting principles generally accepted in the
United States of America. The preparation of these consolidated
condensed financial statements requires us to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenues and expenses, and
related disclosures of contingent assets and liabilities. On an
ongoing basis, we evaluate our estimates, including those related to the
valuation of accounts receivable and inventories, the impairment of long-lived
assets, any potential losses from pending litigation and deferred tax assets or
liabilities. We base our estimates on historical experience and on
various other assumptions that we believe to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying value of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under
different assumptions or conditions; however, we believe that our estimates,
including those for the above-described items, are reasonable.
Development
Stage. We are in the development stage in accordance with
Statements of Financial Accounting Standards (“SFAS”) No. 7 “Accounting and
Reporting by Development Stage Enterprises.” As of October 31, 2008,
we had devoted substantially all of our efforts to financial planning, raising
capital and developing markets.
Stock-based
Compensation. We account for compensation expense for our
stock-based employee compensation plans using the fair value method prescribed
in SFAS No. 123R, “Share-Based Payment” (“SFAS 123R”), which requires us to
recognize the cost of employee services received in exchange for awards of
equity instruments based on the grant-date fair value of the
awards. We previously recognized employee stock-based compensation
under Accounting Principles Board Opinion No. 25 (“APB 25”), “Accounting for
Stock Issued to Employees,” requiring compensation expense of fixed stock
options to be based on the difference, if any, between the deemed fair value of
our stock and the exercise price of the option on the date of the
grant. To transition from APB 25, we applied the modified prospective
application of SFAS 123R, which requires us to recognize compensation cost for
the portion of employee equity awards for which the requisite service has not
been rendered as of February 1, 2006 as the requisite service is rendered on or
after such date.
We
account for stock issued to non-employees in accordance with the provisions of
SFAS 123R and EITF Issue No. 96-18, “Accounting for Equity Instruments That Are
Issued to Other Than Employees for Acquiring, or in Conjunction with Selling,
Goods or Services.”
Pro forma
information regarding the results of operations is calculated as if we had
accounted for our employee stock options using the fair-value
method. The fair value of each option grant is estimated on the date
of grant using the Black-Scholes method.
14
Loss per Common
Share. We report net loss per share using a dual presentation
of basic and diluted loss per share. Basic net loss per share
excludes the impact of common stock equivalents. Diluted net loss per
share utilizes the average market price per share when applying the treasury
stock method in determining common stock equivalents. As of October
31, 2008, there were 6,124,695 and 5,033,364 common stock options and warrants
outstanding, respectively, which were excluded from the calculation of net loss
per share-diluted because they were antidilutive.
Results
of Operations
Three Months
Ended October 31, 2008 and 2007. Salaries, benefits and
payroll taxes totaled $61,335 for the three-month period ended October 31, 2008,
a decrease of $4,379 from prior year total of $65,714. The decrease
for the three-month period was primarily caused by a reduction in
staff.
Stock-based
compensation totaled $0 for the three-month period ended October 31, 2008, a
decrease of $350 over the same period in the prior year. The Company
has no unvested stock options outstanding.
Professional
and consulting fees totaled $23,429 for the three-month period ended October 31,
2008, as compared to $38,607 during the prior year. The lower cost
for the three-month period is due primarily to a reduction in legal
costs.
Travel
expenses totaled $1,991 during the three-month period ended October 31, 2008, as
compared to $5,105 for the prior year.
Contract
labor expenses totaled $37,500 during the three-month period ended October 31,
2008, an amount equal to the total of $37,500 for the same period in the prior
year. The compensation of the chief executive and financial officers
has been accrued. Our officers have been offered Series A Convertible
Preferred Stock at $0.50 per share in exchange for the balance of the accrued
salaries owed to them.
Insurance
expenses totaled $12,475 during the three-month period ended October 31, 2008,
as compared to the prior year total of $12,546.
Depreciation
of $1,395 was recorded during the three-month period ended October 31, 2008, a
decrease of $12,887 for the similar period in the prior
year. Software acquired in July 2008 was fully depreciated during the
prior fiscal year resulting in decreased depreciation for the current
year.
Other
general and administrative expenses totaled $3,199 during the three-month period
ended October 31, 2008, a decrease of $1,650 over the prior year. The
decrease is primarily attributable to a decrease in telephone
expenses.
We
recorded $14,228 in interest expense for the three-month period ended October
31, 2008, as compared to $10,609 in the three-month period ended October 31,
2007. We have loan agreements outstanding this fiscal year that were
not in existence last year. The interest rate for these loans was
9%.
March 1, 2005
(inception) to October 31, 2008. For the period from March 1,
2005 (inception) to October 31, 2008, we were engaged primarily in raising
capital to implement our business plan. Accordingly, we have earned
revenue of only $34,518. We incurred expenses for professional and
consulting fees, salaries and payroll taxes, stock-based compensation, travel,
contract labor, insurance, interest and other expenses resulting in an
accumulated loss of $6,210,402. More than half of the cumulative net
loss is due to the recognition of non-cash stock-based compensation expense for
issuing shares, options, and warrants to employees and third parties in the
amount of $3,190,203. As we develop our business plan, we expect that
cash generated through operations will replace many of the non-cash transaction
structures currently utilized to implement our business plan.
Liquidity
and Capital Resources
Since
inception, we have relied on the sale of equity capital and debt instruments to
fund working capital and the costs of developing our business
plan. For the three months ended October 31, 2008, net cash of
$20,000
15
provided
by financing activities offset the $26,656 used in operating activities
resulting in a $6,656 decrease in cash. We have a working capital
deficit of $1,343,897 at October 31, 2008, primarily as a result of our
outstanding notes being classified as current liabilities due to their maturity
dates falling within one year of the balance sheet date.
As
discussed above, we have had minimal revenues and have accumulated a net loss of
$6,210,402 since inception. Furthermore, we have not commenced our
planned principal operations. Our future is dependent upon our
ability to obtain equity and/or debt financing and upon future profitable
operations from the development of our business plan.
Our
significant operating losses raise substantial doubt about our ability to
continue as a going concern. Historically, we have been able to raise
additional capital sufficient to continue as a going
concern. However, there can be no assurance that this additional
capital will be sufficient for us to implement our business plan or achieve
profitability in our operations. Additional equity or debt financing
will be required to continue as a going concern. If we complete the
transaction with NMKT, the new officers and directors of our Company will assume
responsibility for funding our future operations. Without such
additional capital, either from NMKT or from a debt or equity offering by our
Company, there is doubt as to whether we will continue as a going
concern.
Off
Balance Sheet Arrangements
We do not
have any material off balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures or capital resources.
Factors
That May Affect Our Results of Operations
RISK
FACTORS RELATED TO OUR BUSINESS AND MARKETPLACE
If we complete
our planned transaction with NewMarket Techology, Inc., there will be a change
in control. We have entered into a letter of intent with
NewMarket Technology, Inc. (“NMKT”) whereby it is proposed that NMKT will obtain
a 51% interest in our Company in exchange for payment of $100,000 and assumption
of all of our outstanding debts. If this transaction is completed,
NMKT will have voting control of the Company and will likely put in new
management. The ownership interests of existing shareholders will be
diluted as well.
If we complete
our planned exchange of debt for Series A Convertible Preferred Stock, there
will be a change in control. We have offered all of our
convertible note holders and various other debt holders an exchange of Series A
Convertible Preferred Stock (“Series A”) for the outstanding debts and any
accrued interest at $0.50 per Series A share. All of our debt holders
have indicated that they will exchange their debt for the Series A
shares. If this transaction is completed, the holders of Series A
shares will have 16,285,150 common share votes which is voting control of the
Company. Together, our chief executive officer and chief financial
officer will exercise voting control over the Company. We do not
anticipate that the holders of Series A will appoint new
management. The ownership interests of existing shareholders will be
significantly diluted.
If we do not
complete the change of control transaction with NMKT, we must obtain financing
to continue operations. If we do not complete the transaction
with NMKT, we must engage in debt and/or equity financing in order to continue
operations. We do not know the terms on which any financing might be
available or if such financing is available on any terms. Such terms
may be detrimental to the interests of our existing shareholders. The
value of an investment in our common stock could be reduced. Interest
on debt securities could increase costs and negatively impacts operating
results. In addition to the 5,000,000 shares of Series A Convertible
Preferred Stock that has been authorized, other preferred stock could be issued
in series from time to time with such designations, rights, preferences, and
limitations as needed to raise capital. The terms of such other
preferred stock could be more advantageous to those investors than to the
holders of common stock. In addition, if we need to raise more equity
capital from the sale of common stock, institutional or other investors may
negotiate terms at least as, and possibly more, favorable than the terms given
to our current investors. Shares of common stock that we sell could
be sold into the market, which could adversely affect market price.
16
If we do not
complete the proposed transaction with NMKT, we will seek other merger and
acquisition opportunities. We may not be able to successfully
acquire or merge with another business. Any acquisition or merger
that we undertake will require an unspecified amount of additional capital
expenditure in the form of planning, due diligence, legal, and accounting
fees. We have no substantial experience in completing acquisitions of
or mergers with other businesses, and we may be unable to successfully complete
such a transaction. Any acquisition or merger we undertake may result
in a potentially dilutive issuance of equity securities, the issuance of debt
and incurrence of expenses related to the transaction.
As a development
stage company, we cannot assure you that we will succeed or be
profitable. We have been in business for a little more than
two years. From March 1, 2005 (inception) through October 31, 2008,
we generated revenues of only $34,518 and accumulated a net loss of
$6,210,402. We are in the development stage, as that term is defined
by certain financial accounting standards. This means that as of
October 31, 2008, our planned principal operations had not commenced, as we had
devoted substantially all of our efforts to financial planning, raising capital,
and developing markets. We cannot assure you that we will be
successful or profitable.
As
discussed above, we have had minimal revenues and have accumulated a net loss
since inception. Our future is dependent upon completing the change
of control transaction with NMKT or our ability to obtain equity and/or debt
financing and upon future profitable operations from the development of our
business plan. Therefore, there is substantial doubt that we will be
able to continue as a going concern.
RISK
FACTORS RELATED TO OUR COMMON STOCK
Future equity
transactions, including exercise of options or warrants, could result in
dilution. In order to raise sufficient capital to fund
operations, from time to time, we intend to sell restricted stock, warrants, and
convertible debt to investors in private placements. Because the
stock will be restricted, the stock will likely be sold at a greater discount to
market prices compared to a public stock offering, and the exercise price of the
warrants is likely to be at or even lower than market prices. These
transactions will cause dilution to existing stockholders. Also, from
time to time, options will be issued to officers, directors, or employees, with
exercise prices equal to market. Exercise of in-the-money options and
warrants will result in dilution to existing stockholders. The amount
of dilution will depend on the spread between the market and exercise price, and
the number of shares involved. In addition, such shares would
increase the number of shares in the “public float” and could depress the market
price for our common stock.
Our common stock
is subject to SEC “Penny Stock” rules. Since our common stock
is a penny stock, as defined in Rule 3a51-1 under the Securities Exchange Act,
it will be more difficult for investors to liquidate their investment of our
common stock. Until the trading price of the common stock rises above
$5.00 per share, if ever, trading in the common stock is subject to the penny
stock rules of the Securities Exchange Act specified in Rules 15g-1 through
15g-10. Those rules require broker-dealers, before effecting
transactions in any penny stock, to:
·
|
Deliver
to the customer, and obtain a written receipt for, a disclosure
document;
|
·
|
Disclose
certain price information about the
stock;
|
·
|
Disclose
the amount of compensation received by the broker-dealer or any associated
person of the broker-dealer;
|
·
|
Send
monthly statements to customers with market and price information about
the penny stock; and
|
·
|
In
some circumstances, approve the purchaser’s account under certain
standards and deliver written statements to the customer with information
specified in the rules.
|
Consequently,
the penny stock rules may restrict the ability or willingness of broker-dealers
to sell the common stock and may affect the ability of holders to sell their
common stock in the secondary market and the price at which such holders can
sell any such securities. These additional procedures could also
limit our ability to raise additional capital in the future.
Since our shares
are trading on the “OTC Bulletin Board”, trading volumes and prices may be
sporadic because it is not an exchange. Our common shares are
currently trading on the “OTC Bulletin Board.” The trading price of
our common shares has been subject to wide fluctuations. Trading
prices of our common shares may fluctuate in response to a number of factors,
many of which will be beyond our control. The stock market has
17
generally
experienced extreme price and volume fluctuations that have often been unrelated
or disproportionate to the operating performance of companies with limited
business operations. There can be no assurance that trading prices
and price earnings ratios previously experienced by our common shares will be
matched or maintained. Broad market and industry factors may
adversely affect the market price of our common shares, regardless of our
operating performance.
In the
past, following periods of volatility in the market price of a company’s
securities, securities class-action litigation has often been
instituted. Such litigation, if instituted, could result in
substantial costs for us and a diversion of management’s attention and
resources.
We are subject to
SEC regulations and changing laws, regulations and standards relating to
corporate governance and public disclosure, including the Sarbanes-Oxley Act of
2002, new SEC regulations and other trading market rules, are creating
uncertainty for public companies. We are committed to
maintaining high standards of corporate governance and public
disclosure. As a result, we intend to invest appropriate resources to
comply with evolving standards, and this investment may result in increased
general and administrative expenses and a diversion of management time and
attention from revenue-generating activities to compliance
activities.
Item
3. Quantitative
and Qualitative Disclosures about Market Risk
Not
Applicable.
Item
4. Controls
and Procedures
As
required by SEC rules, we have evaluated the effectiveness of the design and
operation of our disclosure controls and procedures at the end of the period
covered by this report. This evaluation was carried out under the
supervision and with the participation of our management, including our
principal executive officer and principal financial officer. Based on
this evaluation, these officers have concluded that the design and operation of
our disclosure controls and procedures are effective.
During
our last fiscal quarter, there were no changes in our internal control over
financial reporting or in other factors that have materially affected, or are
reasonably likely to materially affect, our internal control over financial
reporting.
Disclosure
controls and procedures are our controls and other procedures that are designed
to ensure that information required to be disclosed by us in the reports that we
file or submit under the Exchange Act is recorded, processed, summarized and
reported, within the time periods specified in the SEC’s rules and
forms. Disclosure controls and procedures include, without
limitation, controls and procedures designed to ensure that information required
to be disclosed by us in the reports that we file under the Exchange Act is
accumulated and communicated to our management, including principal executive
officer and principal financial officer, as appropriate, to allow timely
decisions regarding required disclosure.
Part
II. OTHER INFORMATION
Item
1. Legal
Proceedings
None.
Item
1A. Risk
Factors
Not
required of smaller reporting companies.
Item
2. Unregistered
Sales of Equity Securities and Use of Proceeds
None.
18
Item
3. Defaults
Upon Senior Securities
None.
Item
4. Submission
of Matters to a Vote of Security Holders
None.
Item
5. Other
Information
None.
Item
6. Exhibits
Regulation
S-B Number
|
Exhibit
|
2.1
|
Share
Exchange Agreement by and between Worldwide Strategies Incorporated,
Centric Rx, Inc., Jim Crelia, Jeff Crelia, J. Jireh,
Inc. and Canada Pharmacy Express, Ltd. dated as of
June 28, 2007 (1)
|
3.1
|
Amended
and Restated Articles of Incorporation (2)
|
3.2
|
Amended
Bylaws (2)
|
3.3
|
Articles
of Exchange Pursuant to NRS 92A.200 effective July 31, 2007
(3)
|
3.4
|
Certificate
of Change Pursuant to NRS 78.209 effective July 31, 2007
(3)
|
3.5
|
Certificate of Designation Pursuant to NRS 78.1955 effective December 8, 2008 (15) |
3.6
|
Amendment to Certificate of Designation Pursuant to NRS 78.1955 effective December 15, 2008 (16) |
10.1
|
2005
Stock Plan (2)
|
10.2
|
Promissory
Notes to James P.R. Samuels dated February 9, 2006 and April 3, 2006
(4)
|
10.3
|
Promissory
Note to James P.R. Samuels dated April 30, 2006 (5)
|
10.4
|
Promissory
Note to Dirk Nye dated April 30, 2006 (5)
|
10.5
|
Promissory
Note to Dirk Van Keulen dated November 11, 2006 (5)
|
10.6
|
9%
Convertible Promissory Note No. 2006-9 dated November 30, 2006
(6)
|
10.7
|
9%
Convertible Promissory Note No. 2006-10 dated November 27, 2006
(6)
|
10.8
|
9%
Convertible Promissory Note No. 2006-11 dated November 30, 2006
(6)
|
10.9
|
9%
Convertible Promissory Note No. 2006-12 dated December 5, 2006
(6)
|
10.10
|
9%
Convertible Promissory Note No. 2006-13 dated December 21, 2006
(6)
|
10.11
|
9%
Convertible Promissory Note No. 2006-14 dated January 11, 2007
(6)
|
10.12
|
9%
Convertible Promissory Note No. 2007-1 dated February 14, 2007
(8)
|
10.13
|
9%
Convertible Promissory Note No. 2007-3 dated April 5, 2007
(8)
|
10.14
|
9%
Convertible Promissory Note No. 2007-4 dated April 5, 2007
(8)
|
10.15
|
9%
Convertible Promissory Note No. 2007-5 dated April 5, 2007
(8)
|
10.16
|
9%
Convertible Promissory Note No. 2007-6 dated April 5, 2007
(8)
|
10.17
|
9%
Convertible Promissory Note No. 2007-7 dated April 5, 2007
(8)
|
10.18
|
9%
Convertible Promissory Note No. 2007-8 dated April 5, 2007
(8)
|
10.19
|
9%
Convertible Promissory Note No. 2007-9 dated April 5, 2007
(8)
|
10.20
|
9%
Convertible Promissory Note No. 2007-10 dated April 5, 2007
(8)
|
10.21
|
9%
Convertible Promissory Note No. 2007-11 dated June 14, 2007
(9)
|
10.22
|
9%
Convertible Promissory Note No. 2007-12 dated June 13, 2007
(9)
|
10.23
|
9%
Convertible Promissory Note No. 2007-13 dated June 8, 2007
(9)
|
10.24
|
9%
Convertible Promissory Note No. 2007-14 dated June 19, 2007
(9)
|
10.25
|
Escrow
Agreement (3)
|
10.26
|
Lock-up
and Voting Trust Agreement (3)
|
10.27
|
Employment
Agreement with Jim Crelia dated August 1, 2007 (3)
|
10.28
|
Employment
Agreement with Jack West dated August 1, 2007 (3)
|
10.29
|
Employment
Agreement with Peter Longbons dated August 1, 2007 (3)
|
10.30
|
Assignment
of Intellectual Property and Indemnification Agreement with Jeff Crelia
dated July 31, 2007 (3)
|
19
Regulation
S-B Number
|
Exhibit
|
10.31
|
Assignment
of Intellectual Property and Indemnification Agreement with Gregory Kinney
dated July 31, 2007 (3)
|
10.32
|
Assignment
of Intellectual Property and Indemnification Agreement with Rick Brugger
dated July 31, 2007 (3)
|
10.33
|
Assignment
of Intellectual Property and Indemnification Agreement with Todd Hicks
dated July 31, 2007 (3)
|
10.34
|
9%
Convertible Promissory Note No. 2007-16 dated August 23, 2007
(10)
|
10.35
|
9%
Convertible Promissory Note No. 2007-17 dated August 23, 2007
(10)
|
10.36
|
9%
Convertible Promissory Note No. 2007-18 dated August 30, 2007
(10)
|
10.37
|
9%
Convertible Promissory Note No. 2007-19 dated September 14, 2007
(10)
|
10.38
|
9%
Convertible Promissory Note No. 2007-20 dated September 24, 2007
(10)
|
10.39
|
9%
Convertible Promissory Note No. 2007-21 dated October 12, 2007
(10)
|
10.40
|
Employment
Agreement with James P.R. Samuels dated October 12, 2007
(10)
|
10.41
|
Employment
Agreement with W. Earl Somerville dated October 12, 2007
(10)
|
10.42
|
9%
Convertible Promissory Note No. 2007-22 dated October 26, 2007
(11)
|
10.43
|
9%
Convertible Promissory Note No. 2007-23 dated November 16, 2007
(11)
|
10.44
|
9%
Convertible Promissory Note No. 2007-24 dated December 4, 2007
(11)
|
10.45
|
9%
Convertible Promissory Note No. 2007-25 dated December 4, 2007
(11)
|
10.46
|
9%
Convertible Promissory Note No. 2007-26 dated December 4, 2007
(11)
|
10.47
|
9%
Convertible Promissory Note No. 2007-27 dated December 23, 2007
(12)
|
10.48
|
9%
Convertible Promissory Note No. 2008-1 dated January 11, 2008
(12)
|
10.49
|
9%
Convertible Promissory Note No. 2008-2 dated January 22, 2008
(12)
|
10.50
|
9%
Convertible Promissory Note No. 2008-3 dated May 11, 2008
(13)
|
10.51
|
9%
Convertible Promissory Note No. 2008-4 dated June 6, 2008
(13)
|
10.52
|
9%
Convertible Promissory Note No. 2008-5 dated June 12, 2008
(14)
|
10.53
|
9%
Convertible Promissory Note No. 2008-6 dated June 24, 2008
(14)
|
10.54
|
9%
Convertible Promissory Note No. 2008-7 dated June 30, 2008
(14)
|
10.55
|
9%
Convertible Promissory Note No. 2008-8 dated July 30, 2008
(14)
|
31.1
|
Rule
13a-14(a) Certification of James P.R. Samuels
|
31.2
|
Rule
13a-14(a) Certification of W. Earl Somerville
|
32.1
|
Certification
of James P.R. Samuels Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of
2002
|
32.2
|
Certification
of W. Earl Somerville Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of
2002
|
_____________________
(1)
|
Filed
as an exhibit to the Current Report on Form 8-K dated June 28, 2007, filed
July 2, 2007.
|
(2)
|
Filed
as an exhibit to the initial filing of the registration statement on Form
SB-2, File No. 333-129398, on November 2,
2005.
|
(3)
|
Filed
as an exhibit to the Current Report on Form 8-K dated July 31, 2007, filed
August 6, 2007.
|
(4)
|
Filed
as an exhibit to Amendment No. 6 to the registration statement on Form
SB-2, File No. 333-129398, on April 25,
2006.
|
(5)
|
Filed
as an exhibit to the Annual Report on Form 10-KSB, File No. 333-129398, on
October 26, 2006.
|
(6)
|
Filed
as an exhibit to the Current Report on Form 8-K dated November 27, 2006,
filed March 7, 2007.
|
(7)
|
Filed
as an exhibit to the Current Report on Form 8-K dated March 13, 2007,
filed March 15, 2007.
|
(8)
|
Filed
as an exhibit to the Current Report on Form 8-K dated February 14, 2007,
filed June 7, 2007.
|
(9)
|
Filed
as an exhibit to the Current Report on Form 8-K dated June 8, 2007, filed
June 29, 2007.
|
(10)
|
Filed
as an exhibit to the Annual Report on Form 10-KSB, File No. 000-52362, on
November 2, 2007.
|
(11)
|
Filed
as an exhibit to the Quarterly Report on Form 10-QSB, File No. 000-52362,
on December 17, 2007.
|
(12)
|
Filed
as an exhibit to the Quarterly Report on Form 10-QSB, File No. 000-52362,
on March 14, 2008.
|
(13)
|
Filed
as an exhibit to the Quarterly Report on Form 10-QSB, File No. 000-52362,
on June 11, 2008.
|
20
(14)
|
Filed
as an exhibit to the Annual Report on Form 10-K, File No. 000-52362, on
October 29, 2008.
|
(15) | Filed as an exhibit to the Current Report on Form 8-K dated December 8, 2008, filed December 10, 2008. |
(16) | Filed as an exhibit to the Current Report on Form 8-K dated December 15, 2008, filed December 17, 2008. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
WORLDWIDE
STRATEGIES INCORPORATED
|
||
Date: December
18, 2008
|
By:
|
/s/
James P.R. Samuels
|
James
P.R. Samuels
|
||
Chief
Executive Officer
|
||
(Principal
Executive Officer)
|
||
Date: December
18, 2008
|
By:
|
/s/
W. Earl Somerville
|
W.
Earl Somerville
|
||
Chief
Financial Officer, Secretary and Treasurer
|
||
(Principal
Financial Officer and Principal Accounting
Officer)
|
21